Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
301 participants
OBSERVATIONAL
2014-05-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Cataract Surgery Outcome
NCT02182921
Evaluation of the Eyhance and Zoe Lenses
NCT06665659
Visual Performance of Functional Intraocular Lenses in Cataracts
NCT05581888
Visual Outcomes of Functional Intraocular Lenses in Cataracts
NCT06092164
Assessment of Visual Function and Optics in Intraocular Lenses
NCT01654159
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pseudophakic
Administration of patient self-assessment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Administration of patient self-assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pseudophakic patients who have been bilaterally implanted with the same type of intraocular lenses in both eyes
* Ability to understand, read and write English to give consent and complete the study questionnaires
* Availability, willingness, and sufficient cognitive awareness to comply with examination procedures and study visits
* Signed informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization
Exclusion Criteria
* Patient is pregnant or is lactating
* Concurrent participation or participation within 30 days prior in any other clinical trial
22 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Optics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Daniel Chang, M.D.
Bakersfield, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QPRO-101-SIVQ
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.